Emergency contraception
A trial by the World Health Organization published in 1998 established "levonorgestrel only" as the gold standard in hormonal emergency contraception.1 Over 80 countries have now approved dedicated emergency contraception products containing progestogen only, that are often available direc...
Gespeichert in:
| Veröffentlicht in: | BMJ 2003-04, Vol.326 (7393), p.775-776 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 776 |
|---|---|
| container_issue | 7393 |
| container_start_page | 775 |
| container_title | BMJ |
| container_volume | 326 |
| creator | Webb, Anne M C |
| description | A trial by the World Health Organization published in 1998 established "levonorgestrel only" as the gold standard in hormonal emergency contraception.1 Over 80 countries have now approved dedicated emergency contraception products containing progestogen only, that are often available directly from pharmacies. Innovative strategies to improve access are also proliferating, expanding the ranks of those who can supply to nurses and other health workers, and offering supplies to women in advance. |
| doi_str_mv | 10.1136/bmj.326.7393.775 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73194065</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4006591391</sourcerecordid><originalsourceid>FETCH-LOGICAL-b3815-f3748b8b28356e3b06d1c5a8402ea53e0968ea1b9b0bb4e7c4467f0ef0113b73</originalsourceid><addsrcrecordid>eNqFkMtLw0AQhxdRbKk960lEwYukzmSyr6OE-gBR0CLelmy6kdYmqbst2P_eLS0Kgniaw3y_eXyMHSEMEElc2no6oFQMJGkaSMl3WBczoRKuiHZZFzTXiUJSHdYPYQoAKUmlBd9nHUyF0ppjlx0Oa-ffXFOuTsq2WfiidPPFpG0O2F5VzILrb2uPja6Ho_w2uX-8ucuv7hNLCnlSkcyUVTZVxIUjC2KMJS9UBqkrODnQQrkCrbZgbeZkmWVCVuAqiC9YST12vhk79-3H0oWFqSehdLNZ0bh2GYwk1BkIHsHTX-C0XfomnmZSyCD6IIjQ2V8QSikFokQRKdhQpW9D8K4ycz-pC78yCGZt1kSzJpo1a7Mmmo2R4-3gpa3d-Cew9RiBZANMwsJ9fvcL_26EJMnNw0tu8BUwfxJoniN_seHXq_5d_wX6BYyq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777611716</pqid></control><display><type>article</type><title>Emergency contraception</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Webb, Anne M C</creator><creatorcontrib>Webb, Anne M C</creatorcontrib><description>A trial by the World Health Organization published in 1998 established "levonorgestrel only" as the gold standard in hormonal emergency contraception.1 Over 80 countries have now approved dedicated emergency contraception products containing progestogen only, that are often available directly from pharmacies. Innovative strategies to improve access are also proliferating, expanding the ranks of those who can supply to nurses and other health workers, and offering supplies to women in advance.</description><edition>International edition</edition><identifier>ISSN: 0959-8138</identifier><identifier>ISSN: 0959-8146</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.326.7393.775</identifier><identifier>PMID: 12689951</identifier><identifier>CODEN: BMJOAE</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Adult ; Birth control ; Clinical trials ; Clinical Trials as Topic ; Contraceptives, Postcoital, Hormonal - administration & dosage ; Emergency services ; Female ; Health Services Accessibility ; Humans ; Levonorgestrel - administration & dosage ; Mifepristone - administration & dosage ; Risk Factors ; Sexually Transmitted Diseases - diagnosis ; Time Factors</subject><ispartof>BMJ, 2003-04, Vol.326 (7393), p.775-776</ispartof><rights>2003 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2003 (c) 2003 BMJ Publishing Group Ltd.</rights><rights>Copyright BMJ Publishing Group Apr 12, 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b3815-f3748b8b28356e3b06d1c5a8402ea53e0968ea1b9b0bb4e7c4467f0ef0113b73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904,30978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12689951$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Webb, Anne M C</creatorcontrib><title>Emergency contraception</title><title>BMJ</title><addtitle>BMJ</addtitle><description>A trial by the World Health Organization published in 1998 established "levonorgestrel only" as the gold standard in hormonal emergency contraception.1 Over 80 countries have now approved dedicated emergency contraception products containing progestogen only, that are often available directly from pharmacies. Innovative strategies to improve access are also proliferating, expanding the ranks of those who can supply to nurses and other health workers, and offering supplies to women in advance.</description><subject>Adult</subject><subject>Birth control</subject><subject>Clinical trials</subject><subject>Clinical Trials as Topic</subject><subject>Contraceptives, Postcoital, Hormonal - administration & dosage</subject><subject>Emergency services</subject><subject>Female</subject><subject>Health Services Accessibility</subject><subject>Humans</subject><subject>Levonorgestrel - administration & dosage</subject><subject>Mifepristone - administration & dosage</subject><subject>Risk Factors</subject><subject>Sexually Transmitted Diseases - diagnosis</subject><subject>Time Factors</subject><issn>0959-8138</issn><issn>0959-8146</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><sourceid>7QJ</sourceid><recordid>eNqFkMtLw0AQhxdRbKk960lEwYukzmSyr6OE-gBR0CLelmy6kdYmqbst2P_eLS0Kgniaw3y_eXyMHSEMEElc2no6oFQMJGkaSMl3WBczoRKuiHZZFzTXiUJSHdYPYQoAKUmlBd9nHUyF0ppjlx0Oa-ffXFOuTsq2WfiidPPFpG0O2F5VzILrb2uPja6Ho_w2uX-8ucuv7hNLCnlSkcyUVTZVxIUjC2KMJS9UBqkrODnQQrkCrbZgbeZkmWVCVuAqiC9YST12vhk79-3H0oWFqSehdLNZ0bh2GYwk1BkIHsHTX-C0XfomnmZSyCD6IIjQ2V8QSikFokQRKdhQpW9D8K4ycz-pC78yCGZt1kSzJpo1a7Mmmo2R4-3gpa3d-Cew9RiBZANMwsJ9fvcL_26EJMnNw0tu8BUwfxJoniN_seHXq_5d_wX6BYyq</recordid><startdate>20030412</startdate><enddate>20030412</enddate><creator>Webb, Anne M C</creator><general>British Medical Journal Publishing Group</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QJ</scope><scope>7X8</scope></search><sort><creationdate>20030412</creationdate><title>Emergency contraception</title><author>Webb, Anne M C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b3815-f3748b8b28356e3b06d1c5a8402ea53e0968ea1b9b0bb4e7c4467f0ef0113b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Birth control</topic><topic>Clinical trials</topic><topic>Clinical Trials as Topic</topic><topic>Contraceptives, Postcoital, Hormonal - administration & dosage</topic><topic>Emergency services</topic><topic>Female</topic><topic>Health Services Accessibility</topic><topic>Humans</topic><topic>Levonorgestrel - administration & dosage</topic><topic>Mifepristone - administration & dosage</topic><topic>Risk Factors</topic><topic>Sexually Transmitted Diseases - diagnosis</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Webb, Anne M C</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Webb, Anne M C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emergency contraception</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>2003-04-12</date><risdate>2003</risdate><volume>326</volume><issue>7393</issue><spage>775</spage><epage>776</epage><pages>775-776</pages><issn>0959-8138</issn><issn>0959-8146</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><coden>BMJOAE</coden><abstract>A trial by the World Health Organization published in 1998 established "levonorgestrel only" as the gold standard in hormonal emergency contraception.1 Over 80 countries have now approved dedicated emergency contraception products containing progestogen only, that are often available directly from pharmacies. Innovative strategies to improve access are also proliferating, expanding the ranks of those who can supply to nurses and other health workers, and offering supplies to women in advance.</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>12689951</pmid><doi>10.1136/bmj.326.7393.775</doi><tpages>2</tpages><edition>International edition</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-8138 |
| ispartof | BMJ, 2003-04, Vol.326 (7393), p.775-776 |
| issn | 0959-8138 0959-8146 1468-5833 1756-1833 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73194065 |
| source | Applied Social Sciences Index & Abstracts (ASSIA); Jstor Complete Legacy; MEDLINE; Alma/SFX Local Collection |
| subjects | Adult Birth control Clinical trials Clinical Trials as Topic Contraceptives, Postcoital, Hormonal - administration & dosage Emergency services Female Health Services Accessibility Humans Levonorgestrel - administration & dosage Mifepristone - administration & dosage Risk Factors Sexually Transmitted Diseases - diagnosis Time Factors |
| title | Emergency contraception |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A37%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emergency%20contraception&rft.jtitle=BMJ&rft.au=Webb,%20Anne%20M%20C&rft.date=2003-04-12&rft.volume=326&rft.issue=7393&rft.spage=775&rft.epage=776&rft.pages=775-776&rft.issn=0959-8138&rft.eissn=1468-5833&rft.coden=BMJOAE&rft_id=info:doi/10.1136/bmj.326.7393.775&rft_dat=%3Cproquest_cross%3E4006591391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777611716&rft_id=info:pmid/12689951&rfr_iscdi=true |